Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 87,570 | 0 | 0 | 38,592 | 439 |
| Gross Profit | 87,570 | N/A | N/A | 38,592 | 439 |
| Operating Expenses | 19,600 | 14,358 | 14,543 | 16,075 | 16,771 |
| Operating Income | 67,970 | -14,358 | -14,543 | 22,517 | -16,332 |
| Other Income | -622 | -1,416 | -264 | 53 | 378 |
| Pre-tax Income | 67,348 | -15,774 | -14,807 | 22,570 | -15,954 |
| Net Income Continuous | 67,348 | -15,774 | -14,807 | 22,570 | -15,954 |
| Net Income | $67,348 | $-15,774 | $-14,807 | $22,570 | $-15,954 |
| EPS Basic Total Ops | 1.69 | -0.39 | -0.44 | 0.81 | -0.57 |
| EPS Basic Continuous Ops | 1.70 | -0.39 | -0.44 | 0.81 | -0.57 |
| EPS Diluted Total Ops | 1.59 | -0.39 | -0.44 | 0.81 | -0.57 |
| EPS Diluted Continuous Ops | 1.66 | -0.39 | -0.44 | 0.73 | -0.57 |
| EBITDA(a) | $68,383 | $-13,943 | $-14,163 | $22,932 | $-15,969 |